Insider · CIK 0001706301
Sarah B. Noonberg
Files at NGNE (Neurogene Inc.), MGX (Metagenomi, Inc.). First filing Jun 9, 2025, latest Jun 9, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MGX: Metagenomi, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Metagenomi, Inc. | $9,168 5,239 shares | -5% | +37% from low-59% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | NGNE Neurogene Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +12,050 | $0.00 | $0 | 12,050 | Jun 13, 2025 |
| Jun 6, 2025 | MGX Metagenomi, Inc. | SOpen-market sale Common Stock | -5,239 | $1.75 | $9,168 | 109,135 | Jun 9, 2025 |
| Apr 1, 2025 | MGX Metagenomi, Inc. | AGrant or award Common Stock | +14,000 | $0.00 | $0 | 114,374 | Apr 3, 2025 |
| Apr 1, 2025 | MGX Metagenomi, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +84,000 | $0.00 | $0 | 84,000 | Apr 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.